Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle
Yao Fan, Haiping Li, Xiaolong Liang, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 19934-19946
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Mechanisms of Polycomb group protein function in cancer
Victoria Parreno, Anne‐Marie Martinez, Giacomo Cavalli
Cell Research (2022) Vol. 32, Iss. 3, pp. 231-253
Open Access | Times Cited: 103
Circular RNA hsa_circ_000984 promotes colon cancer growth and metastasis by sponging miR-106b
Xiaowu Xu, Boan Zheng, Zhiming Hu, et al.
Oncotarget (2017) Vol. 8, Iss. 53, pp. 91674-91683
Open Access | Times Cited: 108
Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development
André J. van Wijnen, Leila Bagheri, Amr A. Badreldin, et al.
Bone (2020) Vol. 143, pp. 115659-115659
Closed Access | Times Cited: 80
Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma
Carmen Oi Ning Leung, Yang Yang, Rainbow Wing Hei Leung, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma
Xiaoping Zhong, Anna Kan, Wancong Zhang, et al.
Aging (2019) Vol. 11, Iss. 15, pp. 5483-5497
Open Access | Times Cited: 55
CBX3 promotes proliferation and regulates glycolysis via suppressing FBP1 in pancreatic cancer
Lianyu Chen, Chien‐shan Cheng, Chao Qu, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 500, Iss. 3, pp. 691-697
Closed Access | Times Cited: 54
CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis
Shupeng Zhao, Fan Wang, Ming Yang, et al.
Journal of Neuro-Oncology (2019) Vol. 145, Iss. 1, pp. 35-48
Closed Access | Times Cited: 46
Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF‐α pathway in human colon cancer
Mingfen Lai, Guiju Liu, Ruijun Li, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 9, pp. 5021-5027
Open Access | Times Cited: 46
CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma
Chao Ma, Xing‐Guo Nie, Yanli Wang, et al.
Molecular Medicine Reports (2019)
Open Access | Times Cited: 45
MicroRNA-377: A therapeutic and diagnostic tumor marker
Iman Akhlaghipour, Negin Taghehchian, Amir Sadra Zangouei, et al.
International Journal of Biological Macromolecules (2022) Vol. 226, pp. 1226-1235
Closed Access | Times Cited: 24
CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non–small cell lung cancer
Shih‐Chieh Chang, Yi‐Chun Lai, Yen‐Chung Chen, et al.
Asia-Pacific Journal of Clinical Oncology (2017) Vol. 14, Iss. 5
Closed Access | Times Cited: 47
Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression
Lianyu Chen, Chien‐shan Cheng, Chao Qu, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 6, pp. 1768-1768
Open Access | Times Cited: 43
Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation
Cheng Zhang, Dan Chen, Eithne Margaret Maguire, et al.
Cardiovascular Research (2017) Vol. 114, Iss. 3, pp. 443-455
Open Access | Times Cited: 42
CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma
Huayong Zhang, Wei-Chao Chen, Xiao-yan Fu, et al.
Gene (2018) Vol. 654, pp. 49-56
Closed Access | Times Cited: 41
m5C modification of LINC00324 promotes angiogenesis in glioma through CBX3/VEGFR2 pathway
Aini Pan, Yixue Xue, Xuelei Ruan, et al.
International Journal of Biological Macromolecules (2023) Vol. 257, pp. 128409-128409
Closed Access | Times Cited: 12
Chromobox proteins in cancer: Multifaceted functions and strategies for modulation (Review)
Jian Wang, Bo Yang, Xiu‐Hang Zhang, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 3
Open Access | Times Cited: 11
Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma
Siqi Wang, Fang Liu, Yuhui Wang, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 33
The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer
Raheleh Amirkhah, Hojjat Naderi‐Meshkin, Jaynish S. Shah, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 929-929
Open Access | Times Cited: 33
<p>CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses</p>
Hexin Lin, Jiabian Lian, Lu Xia, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 10113-10125
Open Access | Times Cited: 29
NCAPG is transcriptionally regulated by CBX3 and activates the Wnt/β-catenin signaling pathway to promote proliferation and the cell cycle and inhibit apoptosis in colorectal cancer
Hong Yang, Leilei Pu, Ruobing Li, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 2, pp. 900-912
Open Access | Times Cited: 10
Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer
Huaiyuan Liang, Chunguang Yang, Ruijiang Zeng, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 9
Genome editing and cancer: How far has research moved forward on CRISPR/Cas9?
Saikat Mitra, Joyatry Sarker, Anik Mojumder, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113011-113011
Open Access | Times Cited: 15
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Hongjuan Niu, Peiqiong Chen, Lu Fan, et al.
BMC Medical Genomics (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 15
The Heterochromatin protein 1 is a regulator in RNA splicing precision deficient in ulcerative colitis
Jorge Mata-Garrido, Yao Xiang, Yunhua Chang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 14
microRNA‐377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3‐dependent P53/P21 pathway
Zhi‐Sheng He, Junjing Chen, Xiaoliang Chen, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 1, pp. 107-120
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top